Trial intelligence / Profile preview

Oral amiodarone for prevention of atrial fibrillation after open heart surgery

IRCT20151109024975N8Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and arrhythmia comparing Oral amiodarone with Placebo (2 arms). Primary endpoints: Incidence of types of arrhythmia, Duration of ICU admission and 2 more. Started Apr 2016; status: completed.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)arrhythmia

Beyond the preview

Go deeper on IRCT20151109024975N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151109024975N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call